Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study is looking to minimize side effects, while maintaining and potentially improving the therapeutic benefit to patients suffering from Female Sexual Arousal Disorder by providing a topical preparation of Sildenafil locally to the vulvar-vaginal tissue.
Epistemonikos ID: bbf65aaf2902b15e2d44833b213ad461bc9cd49e
First added on: May 09, 2024